The stock of Elevance Health Inc (NYSE: ELV) has decreased by -2.93 when compared to last closing price of 425.39.Despite this, the company has seen a loss of -1.16% in its stock price over the last five trading days. zacks.com reported 2024-11-12 that ELV encounters headwinds such as higher benefit costs, an increased debt level and member attrition in the Medicaid business, which raise concerns among investors.
Is It Worth Investing in Elevance Health Inc (NYSE: ELV) Right Now?
Elevance Health Inc (NYSE: ELV) has a price-to-earnings ratio that is above its average at 15.05x. The stock has a 36-month beta value of 0.85. Opinions on the stock are mixed, with 13 analysts rating it as a “buy,” 7 as “overweight,” 4 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ELV is 231.02M, and at present, short sellers hold a 1.23% of that float. On November 13, 2024, the average trading volume of ELV was 1.37M shares.
ELV’s Market Performance
ELV stock saw a decrease of -1.16% in the past week, with a monthly decline of -18.88% and a quarterly a decrease of -23.42%. The volatility ratio for the week is 3.12%, and the volatility levels for the last 30 days are 2.97% for Elevance Health Inc (ELV). The simple moving average for the past 20 days is -2.70% for ELV’s stock, with a -19.59% simple moving average for the past 200 days.
Analysts’ Opinion of ELV
BofA Securities, on the other hand, stated in their research note that they expect to see ELV reach a price target of $530, previously predicting the price at $646. The rating they have provided for ELV stocks is “Neutral” according to the report published on July 18th, 2024.
Morgan Stanley gave a rating of “Overweight” to ELV, setting the target price at $643 in the report published on June 24th of the current year.
ELV Trading at -14.61% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.21% of loss for the given period.
Volatility was left at 2.97%, however, over the last 30 days, the volatility rate increased by 3.12%, as shares sank -14.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.56% lower at present.
During the last 5 trading sessions, ELV fell by -1.16%, which changed the moving average for the period of 200-days by -15.13% in comparison to the 20-day moving average, which settled at $424.36. In addition, Elevance Health Inc saw -12.44% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from Kendrick Charles Morgan JR, who sale 7,417 shares at the price of $432.14 back on Oct 18 ’24. After this action, Kendrick Charles Morgan JR now owns 8,423 shares of Elevance Health Inc, valued at $3,205,182 using the latest closing price.
Kendrick Charles Morgan JR, the Director of Elevance Health Inc, proposed sale 7,417 shares at $432.28 during a trade that took place back on Oct 18 ’24, which means that Kendrick Charles Morgan JR is holding shares at $3,206,221 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.28 for the gross margin
The net margin for Elevance Health Inc stands at 0.04. The total capital return value is set at 0.12. Equity return is now at value 15.62, with 5.65 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 0.62. The interest coverage ratio of the stock is 8.34.
Currently, EBITDA for the company is 10.49 billion with net debt to EBITDA at 1.78. When we switch over and look at the enterprise to sales, we see a ratio of 0.66. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.50.
Conclusion
To sum up, Elevance Health Inc (ELV) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
